US-based Supira Medical has completed a $120m Series E funding round, with plans to use the capital to advance its position in the percutaneous ventricular assist device (pVAD) market. A portfolio ...
Technological advancements in treatment options, such as percutaneous ventricular assist devices (pVADs) and extracorporeal membrane oxygenation (ECMO), are improving patient survival rates and ...